Koers Abnova (Taiwan) Corporation. Taipei Exchange
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- TWD | - |
Omzet 2022 | 412 mln. 12,68 mln. 11,68 mln. | Omzet 2023 | 382 mln. 11,77 mln. 10,84 mln. | Marktkapitalisatie | 2,13 mld. 65,48 mln. 60,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 74 mln. 2,28 mln. 2,1 mln. | Nettowinst (verlies) 2023 | 43 mln. 1,32 mln. 1,22 mln. | EV/omzet 2022 | 5,2 x |
Nettoliquiditeiten 2022 | 356 mln. 10,96 mln. 10,09 mln. | Nettoliquiditeiten 2023 | 415 mln. 12,8 mln. 11,78 mln. | EV/omzet 2023 | 4,48 x |
K/w-verhouding 2022 |
33,5
x | K/w-verhouding 2023 |
48,8
x | Werknemers | - |
Dividendrendement 2022 |
1,94% | Dividendrendement 2023 |
2,05% | Vrij verhandelbaar | 73,71% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pei Ju Jih
CEO | Chief Executive Officer | - | 01-07-18 |
Wilber Huang
CHM | Chairman | 58 | - |
I Ling Tung
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yueh Hung Chen
BRD | Director/Board Member | 60 | 19-06-20 |
Wilber Huang
CHM | Chairman | 58 | - |
Jia Hsie Lin
BRD | Director/Board Member | 73 | 23-06-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |
- Beurs
- Aandelen
- Koers 4133
- Koers